Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma-Reply
- PMID: 35771532
- DOI: 10.1001/jamaoncol.2022.2068
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma-Reply
Comment on
-
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.JAMA Oncol. 2022 Apr 1;8(4):553-561. doi: 10.1001/jamaoncol.2021.7366. JAMA Oncol. 2022. PMID: 35175316 Free PMC article. Clinical Trial.
-
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma.JAMA Oncol. 2022 Aug 1;8(8):1223-1224. doi: 10.1001/jamaoncol.2022.2062. JAMA Oncol. 2022. PMID: 35771541 No abstract available.
-
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma.JAMA Oncol. 2022 Aug 1;8(8):1224. doi: 10.1001/jamaoncol.2022.2065. JAMA Oncol. 2022. PMID: 35771563 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
